Actual Medicinal Product (AMP) Mimpara 30mg tablets (Abacus Medicine Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Cinacalcet 30mg film-coated tablets (Aurobindo Pharma – Milpharm Ltd.)

Generic

Cinacalcet

Formulation

Cinacalcet 30mg tablets

Alternative Suppliers (18)

Mimpara 30mg tablets (Amgen Ltd)

Cinacalcet 30mg tablets (Dr Reddy's Laboratories (UK) Ltd)

Cinacalcet 30mg tablets (Macleods Pharma UK Ltd)

Cinacalcet 30mg tablets (Genus Pharmaceuticals Ltd)

Cinacalcet 30mg tablets (Accord Healthcare Ltd)

Cinacalcet 30mg tablets (A A H Pharmaceuticals Ltd)

Cinacalcet 30mg tablets (Alliance Healthcare (Distribution) Ltd)

Cinacalcet 30mg tablets (Torrent Pharma (UK) Ltd)

Cinacalcet 30mg tablets (Medihealth (Northern) Ltd)

Cinacalcet 30mg tablets (Viatris UK Healthcare Ltd)

Cinacalcet 30mg tablets (Tillomed Laboratories Ltd)

Cinacalcet 30mg tablets (DE Pharmaceuticals)

Cinacalcet 30mg tablets (Milpharm Ltd)

Cinacalcet 30mg tablets (Bristol Laboratories Ltd)

Cinacalcet 30mg tablets (Amarox Ltd)

Mimpara 30mg tablets (Abacus Medicine Ltd)

Cinacalcet 30mg tablets (Accord-UK Ltd)

Cinacalcet 30mg tablets (Zentiva Pharma UK Ltd)

Related Formulations (6)

Cinacalcet 30mg tablets

Cinacalcet 60mg tablets

Cinacalcet 90mg tablets

Cinacalcet 1mg granules in capsules for opening

Cinacalcet 2.5mg granules in capsules for opening

Cinacalcet 5mg granules in capsules for opening